Cover Image
市場調查報告書

乳房切片設備的全球市場分析:各檢驗類型 (針切片檢查,外科切片檢查),各產品,導引類別 (超音波,乳房X光攝影定位,磁共振),各地區,市場區隔預測

Breast Biopsy Device Market Analysis By Test Type (Needle Breast Biopsy, Open Surgical Biopsy), By Product, By Guidance Type(Ultrasound-Guided, Mammography-Guided Stereotactic, Magnetic Resonance-Guided), By Region And Segment Forecasts To 2024

出版商 Grand View Research, Inc. 商品編碼 368035
出版日期 內容資訊 英文 84 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
乳房切片設備的全球市場分析:各檢驗類型 (針切片檢查,外科切片檢查),各產品,導引類別 (超音波,乳房X光攝影定位,磁共振),各地區,市場區隔預測 Breast Biopsy Device Market Analysis By Test Type (Needle Breast Biopsy, Open Surgical Biopsy), By Product, By Guidance Type(Ultrasound-Guided, Mammography-Guided Stereotactic, Magnetic Resonance-Guided), By Region And Segment Forecasts To 2024
出版日期: 2016年08月08日 內容資訊: 英文 84 Pages
簡介

本報告提供全球乳房切片設備市場相關調查,彙整產業預測,以及各檢驗類型,各產品,各地區趨勢,及打入市場的主要企業簡介等資料。

第1章 調查方法與範圍

第2章 摘要整理

第3章 市場概要

第4章 市場變動,趨勢,範圍

  • 市場區隔
  • 市場規模與成長預測
  • 市場趨勢
    • 推動市場的要素分析
    • 阻礙市場的要素分析
  • 優先的主要機會
  • SWOT分析
  • 波特產業分析
  • 企業的市場佔有率

第5章 各類型預測及趨勢分析

  • 各類型趨勢分析
  • 針切片檢查
  • 外科切片檢查

第6章 各產品預測及趨勢分析

  • 各用途趨勢分析
    • 切片穿刺針
    • 切片檢查台
    • 本地化線
    • 導引系統
    • 其他

第7章 導引類別及趨勢分析

  • 導引類別趨勢分析
  • 超音波
  • 乳房X光攝影定位
    • 磁共振

第8章 各地區預測

  • 各地區市場佔有率
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 中東·非洲

第9章 競爭環境

  • 企業簡介
  • Company Profiles
    • Becton, Dickinson and Company (BD)
    • C.R Bard, Inc.
    • Devicor Medical Products, Inc.
    • Hologic, Inc.
    • Stryker International, Inc.
    • Argon Medical Devices, Inc.
    • Scion Medical Technologies, LLC
    • Cook Medical, Inc.

圖表

目錄

The breast biopsy device market is expected to reach USD 911.2 million by 2024, according to a new report by Grand View Research, Inc. The Breast biopsy device market is projected to grow at a productive rate in the next few years. The key factors supporting the industry's growth involve the rising awareness levels with regard to diagnostic procedures through cancer screening programs, global rise in breast cancers in women, and the high demand for less-invasive procedures. However, the degree of risk is directly proportional to the extent of procedure invasiveness. Biopsy causes pain and is a stressful procedure for patients, moreover, approximately 60% to 80% of breast biopsies in women result in a benign judgment. Therefore, women are encouraged to consult experts for a second opinion before undergoing a biopsy procedure, which is likely to hinder the growth of the market.

The test type segment is categorized into needle breast biopsies and open surgical biopsies. The former is further segmented into fine-needle aspiration, core-needle, and vacuum-assisted core biopsy. The fine-needle aspiration segment is estimated to hold the largest share for the year 2015 whereas the vacuum-assisted core biopsy segment is anticipated to witness a lucrative growth during the study period. The open surgical biopsy industry is sub-segmented into Incisional biopsy and Excisional biopsy.

On the basis of products, the industry is categorized into needles, tables, localization wires, and guidance systems. Additionally, the guidance systems segment of the industry is further categorized on the basis of imaging systems, such as ultrasound, mammography, and magnetic resonance imaging.

Further key findings from the study suggest:

The Asia Pacific region is anticipated to witness the highest growth rate, with a CAGR of around 12.6% during the forecast period. The high frequencies of breast cancer prevailing in women as well as the increase in awareness of cancer screening programs are the factors fueling the market growth.

North America accounts for the largest market share, followed by the European market. The heightened awareness about breast cancer that advocate regular checkups and screening programs along with the demand for accurate and minimally caustic procedures are factors that are responsible for the rapid market growth.

The mammography-guided stereotactic segment is estimated to hold the largest market share followed by the magnetic resonance imaging-guided category. The rise in demand for rapid and precise diagnostic imaging tools in determining the exact location of the tumor or lump in the breast area is one of the major factors driving the growth of this industry

On the basis of test type, the needle-based biopsy segment accounts for the largest share; this is mainly due to the high demand for minimally invasive procedures. On the other hand, the open surgical biopsies have a probability to witness a decline in the market over the next few years due to the relatively high invasiveness and the risks involved with the procedure.

Some major players in this industry include Becton, Dickenson and Company (BD),C.R Bard, Inc., Devicor medical, Inc., and Hologic, Inc., among others.

Table of Content

Chapter 1. Methodology and Scope

  • 1.1. Research methodology
  • 1.2. Research scope & assumption
  • 1.3. List of data sources

Chapter 2. Executive Summary

Chapter 3. Market Snapshot

Chapter 4. Market Variables, Trends & Scope

  • 4.1. Market segmentation
  • 4.2. Market size and growth prospects, 2013 - 2024
  • 4.3. Breast biopsy devices: Market dynamics
    • 4.3.1. Market Driver Analysis
      • 4.3.1.1. Rising prevalence of breast cancer in women
      • 4.3.1.2. Global awareness and cancer screening programs
      • 4.3.1.3. Demand for alternative, less-invasive and accurate procedures
    • 4.3.2. Market Restraints Analysis
      • 4.3.2.1. Awareness of risks associated with breast biopsies lead to expert second opinions
  • 4.4. Key Opportunities Prioritized
  • 4.5. Breast biopsy devices- SWOT analysis, by factor (political, legal, economic, and technological)
  • 4.6. Industry analysis - Porter's five forces analysis
  • 4.7. Breast biopsy devices: Company market share, 2015

Chapter 5. Market Categorization 1: Test Type Estimates & Trend Analysis

  • 5.1. Breast Biopsy Device Market: Type movement analysis
    • 5.1.1. Needle breast biopsy
      • 5.1.1.1. Fine-needle aspiration
      • 5.1.1.1.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
      • 5.1.1.2. Core-needle aspiration
      • 5.1.1.2.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
      • 5.1.1.3. Vacuum-assisted core biopsy
      • 5.1.1.3.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
    • 5.1.2. Surgical biopsy
      • 5.1.2.1. Incisional breast biopsy
      • 5.1.2.1.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
      • 5.1.2.2. Excisional breast biopsy
      • 5.1.2.2.1. Market estimates and forecasts, 2013 - 2024 (USD Million)

Chapter 6. Market Categorization 2: Product Estimates & Trend Analysis

  • 6.1. Breast Biopsy Device Market: Product movement analysis
    • 6.1.1. Biopsy needles
      • 6.1.1.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
    • 6.1.2. Biopsy tables
      • 6.1.2.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
    • 6.1.3. Localization wires
      • 6.1.3.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
    • 6.1.4. Guidance systems
      • 6.1.4.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
    • 6.1.5. Others
      • 6.1.5.1. Market estimates and forecasts, 2013 - 2024 (USD Million)

Chapter 7. Market Categorization 3: Guidance Type Estimates & Trend Analysis

  • 7.1. Breast Biopsy Device Market: Guidance type movement analysis
    • 7.1.1. Ultrasound-guided
      • 7.1.1.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
    • 7.1.2. Mammography-guided stereotactic
      • 7.1.2.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
    • 7.1.3. Magnetic resonance-guided
      • 7.1.3.1. Market estimates and forecasts, 2013 - 2024 (USD Million)
    • 7.1.4. Others
      • 7.1.4.1. Market estimates and forecasts, 2013 - 2024 (USD Million)

Chapter 8. Market Categorization 4: Regional Estimates & Trend Analysis, by Test Type, Product, &Guidance Type

  • 8.1. Breast Biopsy Device Market share by region, 2016 & 2024
  • 8.2. North America
    • 8.2.1. U.S.
      • 8.2.1.1. Market estimates and forecasts, by test type, 2013 - 2024 (USD Million)
      • 8.2.1.2. Market estimates and forecasts, by product, 2013 - 2024 (USD Million)
      • 8.2.1.3. Market estimates and forecasts, by guidance type, 2013 - 2024 (USD Million)
    • 8.2.2. Canada
      • 8.2.2.1. Market estimates and forecasts, by test type, 2013 - 2024 (USD Million)
      • 8.2.2.2. Market estimates and forecasts, by product, 2013 - 2024 (USD Million)
      • 8.2.2.3. Market estimates and forecasts, by guidance type, 2013 - 2024 (USD Million)
  • 8.3. Europe
    • 8.3.1. Germany
      • 8.3.1.1. Market estimates and forecasts by test type, 2013 - 2024 (USD Million)
      • 8.3.1.2. Market estimates and forecasts, by product, 2013 - 2024 (USD Million)
      • 8.3.1.3. Market estimates and forecasts, by guidance type, 2013 - 2024 (USD Million)
    • 8.3.2. U.K.
      • 8.3.2.1. Market estimates and forecasts, by test type, 2013 - 2024 (USD Million)
      • 8.3.2.2. Market estimates and forecasts, by product, 2013 - 2024 (USD Million)
      • 8.3.2.3. Market estimates and forecasts, by guidance type, 2013 - 2024 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. China
      • 8.4.1.1. Market estimates and forecasts, by test type, 2013 - 2024 (USD Million)
      • 8.4.1.2. Market estimates and forecasts, byproduct, 2013 - 2024 (USD Million)
      • 8.4.1.3. Market estimates and forecasts, by guidance type, 2013 - 2024 (USD Million)
    • 8.4.2. India
      • 8.4.2.1. Market estimates and forecasts, by test type, 2013 - 2024 (USD Million)
      • 8.4.2.2. Market estimates and forecasts, byproduct, 2013 - 2024 (USD Million)
      • 8.4.2.3. Market estimates and forecasts, by guidance type, 2013 - 2024 (USD Million)
  • 8.5. Latin America
    • 8.5.1. Mexico
      • 8.5.1.1. Market estimates and forecasts, by test type, 2013 - 2024 (USD Million)
      • 8.5.1.2. Market estimates and forecasts, by product, 2013 - 2024 (USD Million)
      • 8.5.1.3. Market estimates and forecasts, by guidance type, 2013 - 2024 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Market estimates and forecasts, by test type, 2013 - 2024 (USD Million)
      • 8.5.2.2. Market estimates and forecasts, by product, 2013 - 2024 (USD Million)
      • 8.5.2.3. Market estimates and forecasts, by guidance type, 2013 - 2024 (USD Million)
  • 8.6. MEA
    • 8.6.1. South Africa
      • 8.6.1.1. Market estimates and forecasts, by test type, 2013 - 2024 (USD Million)
      • 8.6.1.2. Market estimates and forecasts, by product, 2013 - 2024 (USD Million)
      • 8.6.1.3. Market estimates and forecasts, by guidance type, 2013 - 2024 (USD Million)
      • 8.6.1.4. Market estimates and forecasts, by testtype, 2013 - 2024 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Company Profiles
    • 9.1.1. Becton, Dickinson and Company (BD)
      • 9.1.1.1. Company Overview
      • 9.1.1.2. Financial Performance
      • 9.1.1.3. Product Benchmarking
      • 9.1.1.4. Strategic Initiatives
    • 9.1.2. C.R Bard, Inc.
      • 9.1.2.1. Company Overview
      • 9.1.2.2. Financial Performance
      • 9.1.2.3. Product Benchmarking
      • 9.1.2.4. Strategic Initiatives
    • 9.1.3. Devicor Medical Products, Inc.
      • 9.1.3.1. Company Overview
      • 9.1.3.2. Financial Performance
      • 9.1.3.3. Product Benchmarking
      • 9.1.3.4. Strategic Initiatives
    • 9.1.4. Hologic, Inc.
      • 9.1.4.1. Company Overview
      • 9.1.4.2. Financial Performance
      • 9.1.4.3. Product Benchmarking
      • 9.1.4.4. Strategic Initiatives
    • 9.1.5. Stryker International, Inc.
      • 9.1.5.1. Company Overview
      • 9.1.5.2. Financial Performance
      • 9.1.5.3. Product Benchmarking
      • 9.1.5.4. Strategic Initiatives
    • 9.1.6. Argon Medical Devices, Inc.
      • 9.1.6.1. Company Overview
      • 9.1.6.2. Financial Performance
      • 9.1.6.3. Product Benchmarking
      • 9.1.6.4. Strategic Initiatives
    • 9.1.7. Scion Medical Technologies, LLC
      • 9.1.7.1. Company Overview
      • 9.1.7.2. Financial Performance
      • 9.1.7.3. Product Benchmarking
      • 9.1.7.4. Strategic Initiatives
    • 9.1.8. Cook Medical, Inc.
      • 9.1.8.1. Company Overview
      • 9.1.8.2. Financial Performance
      • 9.1.8.3. Product Benchmarking
      • 9.1.8.4. Strategic Initiatives

List of Tables

  • 1. North America Breast Biopsy Device Market revenue, bytes type, 2013 - 2024 (USD Million)
  • 2. North America Breast Biopsy Device Market revenue, by product, 2013 - 2024 (USD Million)
  • 3. North America Breast Biopsy Device Market revenue, by guidance, 2013 - 2024 (USD Million)
  • 4. U.S. Breast Biopsy Device Market revenue, by test type, 2013 - 2024 (USD Million)
  • 5. U.S. Breast Biopsy Device Market revenue, byproduct, 2016 - 2024 (USD Million)
  • 6. U.S. Breast Biopsy Device Market revenue, by guidance type, 2016 - 2024 (USD Million)
  • 7. Canada Breast Biopsy Device Market revenue, by test type, 2016 - 2024 (USD Million)
  • 8. Canada Breast Biopsy Device Market revenue, by product, 2016 - 2024 (USD Million)
  • 9. Canada Breast Biopsy Device Market revenue, by guidance type, 2016 - 2024 (USD Million)
  • 10. Europe Breast Biopsy Device Market revenue, by test type, 2016 - 2024 (USD Million)
  • 11. Europe Breast Biopsy Device Market revenue, by product, 2016 - 2024 (USD Million)
  • 12. Europe Breast Biopsy Device Market revenue, by guidance type, 2016 - 2024 (USD Million)
  • 13. Germany Breast Biopsy Device Market revenue, by test type, 2016 - 2024 (USD Million)
  • 14. Germany Breast Biopsy Device Market revenue, by product, 2016 - 2024 (USD Million)
  • 15. Germany Breast Biopsy Device Market revenue, by guidance type, 2016 - 2024 (USD Million)
  • 16. UK Breast Biopsy Device Market revenue, by test type, 2013 - 2024 (USD Million)
  • 17. UK Breast Biopsy Device Market revenue, by product, 2013 - 2024 (USD Million)
  • 18. UK Breast Biopsy Device Market revenue, by guidance type, 2013 - 2024 (USD Million)
  • 19. Asia Pacific Breast Biopsy Device Market revenue, by test type, 2013 - 2024 (USD Million)
  • 20. Asia Pacific Breast Biopsy Device Market revenue, byproduct, 2013 - 2024 (USD Million)
  • 21. Asia Pacific Breast Biopsy Device Market revenue, by guidance type, 2013 - 2024 (USD Million)
  • 22. China Breast Biopsy Device Market revenue, bytes type, 2013 - 2024 (USD Million)
  • 23. China Breast Biopsy Device Market revenue, by product, 2013 - 2024 (USD Million)
  • 24. China Breast Biopsy Device Market revenue, by guidance type, 2013 - 2024 (USD Million)
  • 25. India Breast Biopsy Device Market revenue, by test type, 2013 - 2024 (USD Million)
  • 26. India Breast Biopsy Device Market revenue, by product, 2013 - 2024 (USD Million)
  • 27. India Breast Biopsy Device Market revenue, by guidance type, 2013 - 2024 (USD Million)
  • 28. Latin America Breast Biopsy Device Market revenue, by test type, 2013 - 2024 (USD Million)
  • 29. Latin America Breast Biopsy Device Market revenue, by product, 2013 - 2024 (USD Million)
  • 30. Latin America Breast Biopsy Device Market revenue, by guidance type, 2013 - 2024(USD Million)
  • 31. Brazil Breast Biopsy Device Market revenue, by test type, 2013 - 2024 (USD Million)
  • 32. Brazil Breast Biopsy Device Market revenue, by product, 2013 - 2024 (USD Million)
  • 33. Brazil Breast Biopsy Device Market revenue, by guidance type, 2013 - 2024 (USD Million)
  • 34. Mexico Breast Biopsy Device Market revenue, by test type, 2013 - 2024 (USD Million)
  • 35. Mexico Breast Biopsy Device Market revenue, by product, 2013 - 2024 (USD Million)
  • 36. Mexico Breast Biopsy Device Market revenue, by guidance type, 2013 - 2024 (USD Million)
  • 37. MEA Breast Biopsy Device Market revenue, by test type, 2013 - 2024 (USD Million)
  • 38. MEA Breast Biopsy Device Market revenue, by product, 2013 - 2024 (USD Million)
  • 39. MEA Breast Biopsy Device Market revenue, by guidance type, 2013 - 2024 (USD Million)
  • 40. South Africa breast devices biopsy market revenue, by test type, 2013 - 2024 (USD Million)
  • 41. South Africa breast devices biopsy market revenue, by product, 2013 - 2024 (USD Million)
  • 42. South Africa breast devices biopsy market revenue, by guidance type, 2013 - 2024 (USD Million)
Back to Top